The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.

MLA

Buchynskyi, Mykhailo, et al. “The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.” Viruses (1999-4915), vol. 15, no. 5, May 2023, p. 1072. EBSCOhost, https://doi.org/10.3390/v15051072.

APA

Buchynskyi, M., Kamyshna, I., Oksenych, V., Zavidniuk, N., & Kamyshnyi, A. (2023). The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses (1999-4915), 15(5), 1072. https://doi.org/10.3390/v15051072

Chicago

Buchynskyi, Mykhailo, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, and Aleksandr Kamyshnyi. 2023. “The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.” Viruses (1999-4915) 15 (5): 1072. doi:10.3390/v15051072.